Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Real-time Estimate Cboe BZX 04:17:05 03/09/26 am AEST			5-day change	1st Jan Change
386.80 ^USD	+1.53%		-1.10%	+26.85%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	10.11B	BBB	-
ABBOTT LABORATORIES	188B	BBB
MEDTRONIC PLC	118B	BBB
CENCORA, INC.	63.16B	AA
HOYA CORPORATION	52.01B	AAA
BECTON, DICKINSON AND COMPANY	50.97B	A
DEXCOM, INC.	34.02B	BBB
MEDLINE INC.	30.8B	A
WEST PHARMACEUTICAL SERVICES, INC.	23.83B	AA
TERUMO CORPORATION	23.45B	AA
STERIS PLC	22.39B	AAA	-
SARTORIUS STEDIM BIOTECH	22.03B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.96B	A
SOLVENTUM CORPORATION	15.48B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.32B	A
BAXTER INTERNATIONAL INC.	13.17B	A
ALIGN TECHNOLOGY, INC.	11.01B	A
GLOBUS MEDICAL, INC.	10.81B	CCC
INSULET CORPORATION	10.29B	A
REPLIGEN CORPORATION	9.6B	AA
Average	37.18B	A
Weighted average by Cap.		A